Biosecure compromise in the works, fate uncertain as deadline nears

Congressional staff are finalizing proposed changes to the Biosecure Act that would target specific Chinese companies but would give them opportunities to avoid sanctions.

The goal is to reconcile the views of congressional critics of the bill who have called for greater due process with demands from China hawks to target specific companies. Congressional staff, racing against the clock as the deadline for action nears, are competing for attention in a chaotic political season...